Galectins: a potential pharmacological target

QR Code

Galectins: a potential pharmacological target

Aim. To consider the use of galectin-1 and galectin-3 inhibitors as potential pharmacological targets in antitumor and antifibrotic therapy.The lecture includes the analysis of experimental research and review articles presented in the PubMed database. A brief description of the structure of galecti...

Full description

Saved in:

Bibliographic Details
Main Authors:	V. A. Serebryakova, O. E. Vaizova, E. L. Golovina, V. V. Kochubey
Format:	Article
Language:	English
Published:	Siberian State Medical University (Tomsk) 2024-10-01
Series:	Бюллетень сибирской медицины
Subjects:	galectin-1 galectin-3 galectin inhibitors antitumor immunity tumor fibrosis
Online Access:	https://bulletin.ssmu.ru/jour/article/view/5751
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Galectins, antibodies to them and galectin-3 binding protein in systemic lupus erythematosus
by: L. V. Kondratyeva, et al.
Published: (2025-03-01)

Galectin-1 and Galectin-3 expression in colon cancer and its correlation with tumor invasion, differentiation, and metastatic spread
by: Yu. V. Kolobovnikova, et al.
Published: (2021-12-01)

Galectin-3 in heart recipients
by: A. A. Ulybysheva, et al.
Published: (2019-07-01)

Galectin-3 in heart transplant rejection and fibrosis
by: O. P. Shevchenko, et al.
Published: (2019-10-01)

Galectin-3 in the blood serum of patients with bone tumors
by: N. E. Kushlinskii, et al.
Published: (2023-07-01)

The role of galectin-1 in the T-lymphocytes homeostasis
by: V. D. Yakushina, et al.
Published: (2011-12-01)

GALECTIN-1 AND ITS ROLE IN DEVELOPMENT OF INNATE AND ADAPTIVE IMMUNITY
by: V. D. Yakushina, et al.
Published: (2014-07-01)

GALECTIN 3 AND ALDOSTERONE IN PATIENTS WITH ATRIAL FIBRILLATION AND METABOLIC SYNDROME
by: V. A. lonin, et al.
Published: (2015-04-01)

Effect of a garlic drench on Galectin gene expression in ovine whole blood
by: SreeNavya Inupala, et al.
Published: (2024-12-01)

The Role of Cystatin C and Galectin-3 in Cardiorenal Syndrome
by: Nazar Ahemd Naji, et al.
Published: (2023-02-01)

Diagnostic value of galectin-3 in heart transplant recipients with myocardial complications
by: O. P. Shevchenko, et al.
Published: (2020-04-01)

GALECTIN-3 LEVEL IN pATIENTS WITH mETAbOLIC SYNDROmE AND CORONARY HEART DISEASE
by: O. М. Drapkina, et al.
Published: (2017-03-01)

Galectin-3: role in the formation of various hemodynamic phenotypes of heart failure and interaction with some neurohumoral factors
by: A. K. Kurbonov, et al.
Published: (2020-08-01)

Relationships between the activity of neurohormonal systems and intracardiac hemodynamics in patients with heart failure: focus on galectin-3
by: V. I. Podzolkov, et al.
Published: (2022-05-01)

Clinical and laboratory characteristics of chronic hepatitis C on the early stages of development
by: N. S. Zhevnerova, et al.
Published: (2016-12-01)

Galectin-3 as a Marker of Cardiorenal Syndrome in Patients with Chronic Heart Failure
by: V. I. Podzolkov, et al.
Published: (2022-05-01)

The level of galectin-3 in the blood serum of patients with chronic hepatitis C
by: V. A. Kovalevа, et al.
Published: (2016-07-01)

Galectin-3 in solid organ recipients: role in graft pathology and prospects for use
by: D. A. Velikiy, et al.
Published: (2023-07-01)

PROGNOSTIC SIGNIFICANCE OF GALECTIN-3 LEVEL ASSESSMENT IN METABOLIC SYNDROME PATIENTS WITH HEART FAILURE
by: O. M. Drapkina, et al.
Published: (2017-12-01)

Selective Glycopolymer Inhibitors of Galectin-3: Supportive Anti-Cancer Agents Protecting Monocytes and Preserving Interferon-Gamma Function
by: Filipová M, et al.
Published: (2025-05-01)

GALECTIN-3 — BIOMARKER OF FIBROSIS IN PATIENTS WITH METABOLIC SYNDROME
by: O. M. Drapkina, et al.
Published: (2015-09-01)

Serum sICAM-1 and Galectin-3 Levels in Diabetic Patients with COVID-19
by: Busra Karahan, et al.
Published: (2025-07-01)

Galectins as Master Regulators of Gastric Cancer Progression
by: Bojan Stojanovic, et al.
Published: (2025-07-01)

NEW POSSIBILITIES IN PREOPERATiVE DIAGNOSIS OF NODULAR THYROID DISEASES
by: O. S. Olifirova, et al.
Published: (2012-07-01)

Galectin-1-mediated expression of proteins-regulators of cell cycle and growth factors in gastric cancer
by: Yu. V. Kolobovnikova, et al.
Published: (2018-01-01)

Elevated expression of galectin-3 in excessive scars: A pilot study
by: Victor Freire Salomão Ferreira, et al.
Published: (2024-10-01)

Phenotypic profile of blood monocytes and tumor-associated macrophages in relation to the expression of galectins 1 and 3 in colorectal cancer
by: A. V. Kurnosenko, et al.
Published: (2025-01-01)

Galectin-3 in recipients with kidney graft dysfunction: analysis of predictive significance
by: D. A. Velikiy, et al.
Published: (2024-09-01)

Galectin-3 as a marker and mediator of endogenous inflammation and nitrosylation oxidative stress in patients with chronic heart failure
by: Yu. B. Shchukin, et al.
Published: (2013-04-01)

Galectin-9 influences the Tim-3 molecule expression in natural killer different subpopulations
by: E. G. Orlova, et al.
Published: (2023-06-01)

Galectin-9 and Tim-3 in gastric cancer: a checkpoint axis driving T cell exhaustion and Treg-mediated immunosuppression independently of anti-PD-1 blockade
by: Charlotte N. Hill, et al.
Published: (2025-07-01)

The role of galectin-1 and galectin-3 in the mechanisms of T-cell immune response dysregulation in colon cancer
by: V. S. Poletika, et al.
Published: (2020-10-01)

Galectin-9: diverse roles in skin disease
by: Lin Wang, et al.
Published: (2025-07-01)

Leveraging AI to optimize galectin-3 inhibitors for Alzheimer’s disease: How to move forwards
by: Huiyong Zhang, et al.
Published: (2025-08-01)

AI-driven discovery of brain-penetrant Galectin-3 inhibitors for Alzheimer's disease therapy
by: Xueyan Liu, et al.
Published: (2025-08-01)

THE ROLE OF TRANSFORMING GROWTH FACTOR BETA-1 AND GALECTIN-3 IN FORMATION OF THE LEFT ATRIUM FIBROSIS IN PATIENTS WITH PAROXYSMAL ATRIAL FIBRILLATION AND METABOLIC SYNDROME
by: E. L. Zaslavskaya, et al.
Published: (2018-03-01)

Laboratory biomarker galectin-3 in the diagnostics of myocardial inflammatory changes in patients with atrial fibrillation
by: A. M. Gusakova, et al.
Published: (2023-06-01)

Galectin-3 in tumor-stromal cells enhances gemcitabine resistance in pancreatic adenocarcinoma by suppressing oxidative phosphorylation
by: Yaheng Wu, et al.
Published: (2025-09-01)

Galectin-3 Release in the Bone Marrow Microenvironment Promotes Drug Resistance and Relapse in Acute Myeloid Leukemia
by: Cansu Yıldırım
Published: (2025-06-01)

Diagnostic value of microRNA-27 and -339 in heart transplant recipients with myocardial fibrosis
by: O. P. Shevchenko, et al.
Published: (2021-09-01)